← Open Payments lookup

FAITH NGUYEN: Open Payments

NPI 1699175737 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$587 in 29 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $422 · 2025 $587

Food & beverage: $587
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$161
ABBVIE INC.5$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
Axsome Therapeutics, Inc.3$75
Vanda Pharmaceuticals Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.2$38
Supernus Pharmaceuticals, Inc.1$25
Alkermes, Inc.1$24
Collegium Pharmaceutical, Inc.1$15
Indivior Inc.1$14

Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, FANAPT, TRINTELLIX, Qelbree, ARISTADA.

Industry payments across MD — which companies pay providers there.